Capmatinib-impurities | Pharmaffiliates

Capmatinib

Capmatinib has been used in trials studying the treatment of Melanoma, Gliosarcoma, Solid Tumors, Colorectal Cancer, and Hepatic Impairment, among others.Reference standards of Capmatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Capmatinib - API Standards 
    [catalogue_number] => PA 56 97000
    [category_ids] => ,78,70,82,
    [chemical_name] => 
    [weight] => 412.43
    [form] => C23H17FN6O
    [cas] => 1029712-80-8
    [pslug] => 1029712-80-8-capmatinib-api-pa5697000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 56 97000

Capmatinib - API Standards


  • Catalogue No.:PA 56 97000

  • CAS :

    1029712-80-8

  • Molecular Formula : C23H17FN6O

  • Molecular Weight : 412.43